SHPH

Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SHPH

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/23	05:15	GlobeNewswire Inc.	Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/14	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/14	22:00	GlobeNewswire Inc.	Shuttle Pharma Provides First Quarter 2024 Corporate Update	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/14	06:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/04/24	05:15	GlobeNewswire Inc.	Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/03/22	22:00	PR Newswire (US)	Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/03/09	08:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/03/05	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/02/13	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/02/13	22:00	PR Newswire (US)	Shuttle Pharma Announces Its Intent to Pursue a Rights Offering	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/02/06	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/24	06:30	PR Newswire (US)	Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/08	23:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/08	23:00	PR Newswire (US)	Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/03	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/21	11:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/20	07:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/11	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/11	23:00	PR Newswire (US)	Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/11/30	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/11/14	23:00	PR Newswire (US)	Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/11/14	06:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/31	22:00	PR Newswire (US)	Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/31	06:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/21	05:15	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/21	05:10	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/10	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/10	22:00	PR Newswire (US)	Shuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor Conference	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/06	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc